Viking Therapeutics (VKTX) has a market capitalization of $2.9B, based on 115.3M shares at a price of $24.99 (down 0.5% yesterday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
April 2025 | $24.99 | 86,135,937 | 115,298,999 | $2,881,321,985.01 |
March 2025 | $24.15 | 84,620,992 | 112,069,000 | $2,706,466,350.00 |
February 2025 | $28.87 | 106,357,670 | 112,069,000 | $3,235,432,030.00 |
January 2025 | $32.75 | 70,998,251 | 112,069,000 | $3,670,259,750.00 |
December 2024 | $40.24 | 75,314,548 | 109,037,000 | $4,387,648,880.00 |
November 2024 | $52.94 | 119,132,432 | 109,037,000 | $5,772,418,780.00 |
October 2024 | $72.54 | 79,829,732 | 109,037,000 | $7,909,543,980.00 |
September 2024 | $63.31 | 63,548,853 | 110,910,700 | $7,021,756,417.00 |
August 2024 | $64.12 | 71,800,370 | 110,910,700 | $7,111,594,084.00 |
July 2024 | $57.00 | 91,274,024 | 110,910,700 | $6,321,909,900.00 |
June 2024 | $53.01 | 87,863,686 | 110,390,200 | $5,851,784,502.00 |
May 2024 | $62.26 | 67,999,368 | 110,390,200 | $6,872,893,852.00 |
April 2024 | $79.58 | 59,740,919 | 110,390,200 | $8,784,852,116.00 |
March 2024 | $82.00 | 158,300,622 | 103,457,000 | $8,483,474,000.00 |
February 2024 | $77.05 | 185,493,269 | 103,457,000 | $7,971,361,850.00 |
January 2024 | $24.14 | 56,754,104 | 103,457,000 | $2,497,451,980.00 |
December 2023 | $18.61 | 71,902,367 | 100,113,800 | $1,863,117,818.00 |
November 2023 | $12.22 | 34,280,894 | 100,113,800 | $1,223,390,636.00 |
October 2023 | $9.81 | 48,766,573 | 100,113,800 | $982,116,378.00 |
September 2023 | $11.07 | 44,973,254 | 99,845,700 | $1,105,291,899.00 |
August 2023 | $13.81 | 33,551,929 | 99,845,700 | $1,378,869,117.00 |
July 2023 | $14.50 | 34,881,006 | 99,845,700 | $1,447,762,650.00 |
June 2023 | $16.21 | 78,367,094 | 99,009,700 | $1,604,947,237.00 |
May 2023 | $21.96 | 70,990,245 | 99,009,700 | $2,174,253,012.00 |
April 2023 | $21.31 | 76,338,985 | 99,009,700 | $2,109,896,707.00 |
